| 000 | 01888 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250515183934.0 | ||
| 264 | 0 | _c20100217 | |
| 008 | 201002s 0 0 eng d | ||
| 022 | _a1873-4995 | ||
| 024 | 7 |
_a10.1016/j.jconrel.2009.08.017 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aFu, Ju Yen | |
| 245 | 0 | 0 |
_aTumor regression after systemic administration of tocotrienol entrapped in tumor-targeted vesicles. _h[electronic resource] |
| 260 |
_bJournal of controlled release : official journal of the Controlled Release Society _cDec 2009 |
||
| 300 |
_a95-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xadministration & dosage |
| 650 | 0 | 4 | _aBiological Transport |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Survival _xdrug effects |
| 650 | 0 | 4 | _aChemistry, Pharmaceutical |
| 650 | 0 | 4 | _aDose-Response Relationship, Drug |
| 650 | 0 | 4 | _aDrug Carriers |
| 650 | 0 | 4 | _aDrug Compounding |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aInhibitory Concentration 50 |
| 650 | 0 | 4 | _aInjections, Intravenous |
| 650 | 0 | 4 |
_aLung Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 |
_aReceptors, Transferrin _xmetabolism |
| 650 | 0 | 4 |
_aSolvents _xchemistry |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTocotrienols _xadministration & dosage |
| 650 | 0 | 4 |
_aTransferrin _xchemistry |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 650 | 0 | 4 | _aXenograft Model Antitumor Assays |
| 700 | 1 | _aBlatchford, David R | |
| 700 | 1 | _aTetley, Laurence | |
| 700 | 1 | _aDufès, Christine | |
| 773 | 0 |
_tJournal of controlled release : official journal of the Controlled Release Society _gvol. 140 _gno. 2 _gp. 95-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.jconrel.2009.08.017 _zAvailable from publisher's website |
| 999 |
_c19111175 _d19111175 |
||